Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins.

Adrenoceptors are prototypic members of the superfamily of seven transmembrane domain, G protein-coupled receptors. Study of the properties of several mutationally activated adrenoceptors is deepening understanding of the normal functioning of this ubiquitous class of receptors. The new findings suggest an expansion of the classical ternary complex model of receptor action to include an explicit isomerization of the receptors from an inactive to an active state which couples to the G protein ('allosteric ternary complex model'). This isomerization involves conformational changes which may occur spontaneously, or be induced by agonists or appropriate mutations which abrogate the normal 'constraining' function of the receptor, allowing it to 'relax' into the active conformation. Robert Lefkowitz and colleagues discuss the physiological and pathophysiological implications of these new insights into regulation of receptor activity.

[1]  I. Nishimoto,et al.  Identification of a Gs activator region of the β2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation , 1991, Cell.

[2]  C. Strader,et al.  Structural basis of β‐adrenergic receptor function , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  M. Caron,et al.  Beta-adrenergic receptor kinase: primary structure delineates a multigene family. , 1989, Science.

[4]  P. Molinoff,et al.  Fundamental difference between the molecular interactions of agonists and antagonists with the β-adrenergic receptor , 1979, Nature.

[5]  S. Snyder,et al.  Opiate Receptor Binding of Agonists and Antagonists Affected Differentially by Sodium , 1974 .

[6]  D Rodbard,et al.  Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. , 1992, Molecular pharmacology.

[7]  D. Oprian,et al.  Constitutively active mutants of rhodopsin , 1992, Neuron.

[8]  R. Lefkowitz,et al.  Agonist-specific alterations in receptor binding affinity associated with solubilization of turkey erythrocyte membrane beta adrenergic receptors. , 1978, Molecular pharmacology.

[9]  Elliott M. Ross,et al.  Signal sorting and amplification through G protein-coupled receptors , 1989, Neuron.

[10]  R. Lefkowitz,et al.  A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data. , 1980, Molecular pharmacology.

[11]  M. Caron,et al.  Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. , 1992, The Journal of biological chemistry.

[12]  C. Strader,et al.  Specific activation of Gs by synthetic peptides corresponding to an intracellular loop of the β‐adrenergic receptor , 1991, FEBS letters.

[13]  R. Lefkowitz,et al.  A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. , 1993, The Journal of biological chemistry.

[14]  J. Thorner,et al.  Model systems for the study of seven-transmembrane-segment receptors. , 1991, Annual review of biochemistry.

[15]  R. Lefkowitz,et al.  Magnesium dependence of agonist binding to adenylate cyclase-coupled hormone receptors. , 1978, The Journal of biological chemistry.

[16]  T. Jessell,et al.  Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. , 1989, Science.

[17]  A. Shenker,et al.  Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin (TSH) receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies. , 1992, The Journal of biological chemistry.

[18]  K. Palczewski,et al.  G-protein-coupled receptor kinases. , 1991, Trends in biochemical sciences.

[19]  J. Nadeau,et al.  Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function , 1993, Cell.